ornano x-ray developer b dose 200 litri conc.
cpac italia srl - sviluppatrici - materiali specifici
ornano x-ray developer starter dose 1 litro conc.
cpac italia srl - sviluppatrici - materiali specifici
du-chem developer & fixer
cpac italia srl - sviluppatrici - materiali specifici
ornano x-ray eco developer dose 2x20 litri
cpac italia srl - sviluppatrici - materiali specifici
r-x developer rtu
cpac italia srl - sviluppatrici - materiali specifici
kodak gbx developer and replenisher
carestream health inc - sviluppatrici - materiali specifici
kodak readymatic developer & replenisher
carestream health inc - sviluppatrici - materiali specifici
4x1l kodak dental x ray developer & replenisher
carestream health inc - sviluppatrici - materiali specifici
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicina cloridrato - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agenti antineoplastici - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
interceptor plus
elanco gmbh - milbemicina ossima, lufenuron - milbemicina ossima - 11.5 milligrammo (i); lufenuron - 230 milligrammo (i), milbemicina-ossima - 23 mg; lufenuron - 460 mg, milbemicina-ossima - 2.3 mg; lufenuron - 46 mg, lufenuron - 230 mg; milbemicina-ossima - 11.5 mg, lufenuron - 115 mg; milbemicina-ossima - 5.75 mg, milbemicina-ossima - 11.5 mg; lufenuron - 230 mg, lufenuron - 460 mg; milbemicina-ossima - 23 mg, milbemicina-ossima - 5.75 mg; lufenuron - 115 mg - milbemycin, combinations